Plants Help Pets ™️ 3% of all sales go to the Live Like Roo Foundation supporting Canine Cancer. Plants Help Pets ™️ 3% of all sales go to the Live Like Roo Foundation supporting Canine Cancer.

Los Angeles, CA

Cannabinoids Explained

CBD is only one of approximately 160 Cannabinoids that have been identified out of over 600 chemical compounds found in cannabis.

"CBDa and THCA offer benefits such as anti-inflammatory properties and neuroprotective effects, with evidence suggesting they are more potent in their raw form compared to CBD and THC."


Here are the top 10 Cannabinoids studied.

  1. CBD (Cannabidiol): Widely researched for its anxiolytic, antiepileptic, and anti-inflammatory properties without inducing psychoactive effects.

  2. THC (Delta 9-Tetrahydrocannabinol): Known for its psychoactivity, analgesic, appetite-stimulating, and anti-nausea effects. The most studied cannabinoid.

  3. CBG (Cannabigerol): Investigated for its antibacterial, appetite-stimulating, and potential glaucoma treatment properties.

  4. CBN (Cannabinol): Researched for its sedative effects and antibacterial properties, though less potent than THC.

  5. CBDV (Cannabidivarin): Explored for anticonvulsant and neuroprotective effects, particularly interesting for epilepsy research.

  6. THCV (Tetrahydrocannabivarin): Studied for its appetite-suppressing and anticonvulsant properties, with less psychoactivity than THC.

  7. CBC (Cannabichromene): Known for anti-inflammatory and antibacterial effects.

  8. CBDA (Cannabidiolic Acid): The acidic precursor to CBD, researched for its anti-nausea and anti-inflammatory properties. 

  9. Delta 8-THC (Delta 8-Tetrahydrocannabinol): Similar to Delta 9-THC but with weaker psychoactivity. Studied for appetite-stimulation and anti-nausea effects.

  10. CBGA (Cannabigerolic Acid): The "mother" of other cannabinoids, showing antibacterial and antifungal potentials.


The majority of cannabinoid research, including studies on CBD, THC, and other cannabinoids, is being conducted in a variety of countries around the world, with significant contributions from the United States, Canada, Israel, and several European countries. The distribution of research efforts is influenced by the legal status of cannabis and cannabinoids, funding availability, and the presence of research institutions with expertise in cannabinoid science. Here's a closer look at where most studies are being held:

United States

  • The United States has a growing body of research on cannabinoids, particularly CBD and THC, thanks to changes in legal status in many states and increased interest from the medical community. Research institutions and universities across the country are conducting studies, although federal restrictions on cannabis still pose challenges for research.


  • Canada is a leader in cannabis research, particularly after legalizing cannabis for both medical and recreational use at the federal level in 2018. This legal landscape has facilitated extensive research on various cannabinoids for a range of medical conditions.


  • Israel is considered a pioneer in cannabinoid research and has contributed significantly to the global understanding of cannabis and its effects. The country's research is led by prominent scientists in the field, such as Dr. Raphael Mechoulam, and supported by institutions like the Hebrew University of Jerusalem.


  • Several European countries have active research programs on cannabinoids. The Netherlands, the United Kingdom, and Spain, among others, have been notable contributors to cannabinoid research, exploring its therapeutic potential and mechanisms of action.


  • Australia has been increasing its focus on cannabinoid research, particularly for medical cannabis, with studies spanning pain management, epilepsy, and other conditions.

Global Collaborations

  • Many studies involve international collaborations, pooling resources and expertise from researchers around the world. These collaborations are vital for advancing the understanding of cannabinoids and overcoming legal and logistical barriers to research.

Key Research Areas

  • Clinical Trials: Conducted globally to assess the efficacy and safety of cannabinoids in treating various medical conditions.
  • Pharmacology: Studies exploring the mechanisms of action of different cannabinoids.
  • Agricultural Research: Focused on cannabis cultivation, strain development, and the optimization of cannabinoid profiles.
  • Regulatory Science: Research aimed at informing policy and regulatory frameworks for medical cannabis.